Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Nevro Corp. (NVRO)

139.3   0.58 (0.42%) 10-01 09:21
Open: 139.09 Pre. Close: 138.72
High: 140.62 Low: 137.27
Volume: 273,289 Market Cap: 4,780M
Nevro Corp. engages in the provision of medical devices. The company is headquartered in Redwood City, California and currently employs 804 full-time employees. The firm focuses on providing products that improve the quality of life of patients suffering from chronic pain. The firm has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy enables patients to achieve sustained pain relief without paresthesia, thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia. HF10 therapy relies on consistent anatomical lead placement. As of December 31, 2016, it was investigating the use of HF10 therapy to address additional indications, such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. The Senza system is approved to create electrical impulses from 2 hertz (Hz) to 10,000 Hz.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 142.715 - 143.525 143.525 - 144.406
Low: 135.668 - 136.558 136.558 - 137.524
Close: 137.041 - 138.589 138.589 - 140.27

Technical analysis

as of: 2020-09-30 4:44:45 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 165.06     One year: 173.60
Support: Support1: 129.50    Support2: 107.74
Resistance: Resistance1: 141.32    Resistance2: 148.63
Pivot: 140.99
Moving Average: MA(5): 139.65     MA(20): 140.60
MA(100): 129.92     MA(250): 118.06
MACD: MACD(12,26): 1.11     Signal(9): 1.73
Stochastic oscillator: %K(14,3): 41.78     %D(3): 46.73
RSI: RSI(14): 49.30
52-week: High: 148.63  Low: 65.05  Change(%): 72.2
Average Vol(K): 3-Month: 28610  10-Days: 28149

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NVRO has closed above bottom band by 28.1%. Bollinger Bands are 31.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 24 Sep 2020
Brokerages Expect Nevro Corp (NYSE:NVRO) Will Post Quarterly Sales of $103.56 Million - MarketBeat

Mon, 21 Sep 2020
Can You Imagine How Jubilant Nevro's (NYSE:NVRO) Shareholders Feel About Its 218% Share Price Gain? - Yahoo Finance

Thu, 17 Sep 2020
Insider Selling: Nevro Corp (NYSE:NVRO) Director Sells 2,000 Shares of Stock - MarketBeat

Thu, 17 Sep 2020
Nevro Bolsters Growth Prospects With New Manufacturing Plan - Nasdaq

Mon, 14 Sep 2020
Nevro (NVRO) Initiates Plan for Manufacturing Operations in Costa Rica to Support Future Growth -

Mon, 14 Sep 2020
Nevro Initiates Plan for Manufacturing Operations in Costa Rica to Support Future Growth - PRNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 34
Shares Float (M) 34
% Held by Insiders 2.32
% Held by Institutions 105.23
Shares Short (K) 2,400
Shares Short P. Month (K) 2,280

Stock Financials

EPS -3.050
EPS Est This Year -1.160
EPS Est Next Year -0.090
Book Value (p.s.) 10.920
Profit Margin -27.22
Operating Margin -23.58
Return on Assets (ttm) -8.8
Return on Equity (ttm) -33.9
Qtrly Rev. Growth -39.7
Gross Profit (p.s.) 7.821
Sales Per Share 10.446
EBITDA (p.s.) -2.321
Qtrly Earnings Growth
Operating Cash Flow (M) -39
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -45.48
PEG Ratio
Price to Book value 12.70
Price to Sales 13.28
Price to Cash Flow -122.51

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.